India-focused private equity fund manager InvAscent has reached a second close for India Life Sciences Fund III with US$210 million in capital commitments, reportedly surpassing its US$200 million target. India Life Sciences Fund III will invest between US$10 million and US$40 million in India-based companies in the pharmaceutical, health care and medical technology sectors.